Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease (Q30307687)

16 June 2017

1 reference

title

Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease (English)

1 reference

16 June 2017

1 reference

1 reference

1 reference

Wooten GF

1

1 reference

16 June 2017

language of work or name

1 reference

1 October 2001

1 reference

16 June 2017

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

16 June 2017

volume

8

1 reference

16 June 2017

issue

2

1 reference

16 June 2017

page(s)

79-83

1 reference

Cloning of the cDNA and gene for a human D2 dopamine receptor

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Human dopamine D1 receptor encoded by an intronless gene on chromosome 5

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Chromosomal localization of the human D3 dopamine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Selective localization of striatal D1 receptors to striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Nigral dopamine autoreceptors are exclusively of the D2 type: quantitative autoradiography of [125I]iodosulpride and [125I]SCH 23982 in adjacent brain sections

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Timing of levodopa therapy: evidence from MPTP-treated primates

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

NMDA receptor blockade reverses motor response alterations induced by levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Research Diagnoses for Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900020-7

7 January 2021

10.1016/S1353-8020(01)00020-7

Identifiers

DOI

1 reference

release_e6npfyflvnel5bc2too6hcmkei

16 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e6npfyflvnel5bc2too6hcmkei

24 November 2022

mapped directly with Wikidata item

1 reference